Anthem Biosciences Limited
360 ONE bought 3,35,661 shares of Anthem Biosciences for ₹25.00 Cr at ₹744.80 apiece in a block deal. This was part of a larger transaction where promoter Aruna Ganesh sold a 3.05% stake in the company.
A biotechnology company providing contract research, development, and manufacturing services alongside specialty ingredients production. Established in 2006, the company serves pharmaceutical and nutraceutical sectors through its integrated CRDMO capabilities and custom synthesis expertise. Its distinctive position lies in combining comprehensive development expertise with in-house manufacturing facilities, enabling end-to-end solutions for clients requiring specialized ingredient formulation, process optimization, and commercial-scale production services.
Mumbai-based wealth and asset manager, formerly IIFL Wealth. India's largest listed wealth manager, with the PMS arm running 23 discretionary equity strategies for HNI and family-office capital. One of the largest equity PMS providers in India by AUM.